Near-Field Microwave Microscopy of Materials Properties

Near-field microwave microscopy has created the opportunity for a new class of electrodynamics experiments of materials. Freed from the constraints of traditional microwave optics, experiments can be carried out at high spatial resolution over a broad frequency range. In addition, the measurements can be done quantitatively so that images of microwave materials properties can be created. We review the five major types of near-field microwave microscopes and discuss our own form of microscopy in detail. Quantitative images of microwave sheet resistance, dielectric constant, and dielectric tunability are presented and discussed. Future prospects for near-field measurements of microwave electrodynamic properties are also presented.Comment: 31 pages, 9 figures, lecture given at the 1999 NATO ASI on Microwave Superconductivity Changes suggested by editor, including full reference

Nonadiabatic noncyclic geometric phase of a spin-1/2 particle subject to an arbitrary magnetic field

We derive a formula of the nonadiabatic noncyclic Pancharatnam phase for a quantum spin-1/2 particle subject to an arbitrary magnetic field. The formula is applied to three specific kinds of magneic fields. (i) For an orientated magnetic field, the Pancharatnam phase is derived exactly. (ii) For a rotating magnetic field, the evolution equation is solved analytically. The Aharonov-Anandan phase is obtained exactly and the Pancharatnam phase is computed numerically. (iii) We propose a kind of topological transition in one-dimensional mesoscopic ring subject to an in-plane magnetic field, and then address the nonadiabatic noncyclic effect on this phenomenon.Comment: 6 pages and 3 figure

Near-infrared observations of galaxies in Pisces-Perseus: I. H-band surface photometry of 174 spirals

We present near-infrared, H-band (1.65 um), surface photometry of 174 spiral galaxies in the area of the Pisces-Perseus supercluster. The images, acquired with the ARNICA camera mounted on various telescopes, are used to derive radial profiles of surface brightness, ellipticities, and position angles, together with global parameters such as H-band magnitudes and diameters. The mean relation between H-band isophotal diameter D_{21.5} and the B-band D_{25} implies a B-H color of the outer disk bluer than 3.5; moreover, D_{21.5}/D_{25} depends on (global) color and absolute luminosity. The correlations among the various photometric parameters suggest a ratio between isophotal radius D_{21.5}/2 and disk scale length of about 3.5 and a mean disk central brightness of 17.5 H-mag arcsec^{-2}. We confirm the trend of the concentration index C_{31} with absolute luminosity and, to a lesser degree, with morphological type. We also assess the influence of non-axisymmetric structures on the radial profiles and on the derived parameters.Comment: 10 pages, 11 postscript figures (one table and one figure are available only at the CDS); to be published on A&A

Extended thromboprophylaxis with betrixaban in acutely ill medical patients

BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. METHODS: Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once daily) for 10±4 days plus oral betrixaban placebo for 35 to 42 days or subcutaneous enoxaparin placebo for 10±4 days plus oral betrixaban (at a dose of 80 mg once daily) for 35 to 42 days. We performed sequential analyses in three prespecified, progressively inclusive cohorts: patients with an elevated d-dimer level (cohort 1), patients with an elevated d-dimer level or an age of at least 75 years (cohort 2), and all the enrolled patients (overall population cohort). The statistical analysis plan specified that if the between-group difference in any analysis in this sequence was not significant, the other analyses would be considered exploratory. The primary efficacy outcome was a composite of asymptomatic proximal deep-vein thrombosis and symptomatic venous thromboembolism. The principal safety outcome was major bleeding. RESULTS: A total of 7513 patients underwent randomization. In cohort 1, the primary efficacy outcome occurred in 6.9% of patients receiving betrixaban and 8.5% receiving enoxaparin (relative risk in the betrixaban group, 0.81; 95% confidence interval [CI], 0.65 to 1.00; P=0.054). The rates were 5.6% and 7.1%, respectively (relative risk, 0.80; 95% CI, 0.66 to 0.98; P=0.03) in cohort 2 and 5.3% and 7.0% (relative risk, 0.76; 95% CI, 0.63 to 0.92; P=0.006) in the overall population. (The last two analyses were considered to be exploratory owing to the result in cohort 1.) In the overall population, major bleeding occurred in 0.7% of the betrixaban group and 0.6% of the enoxaparin group (relative risk, 1.19; 95% CI, 0.67 to 2.12; P=0.55). CONCLUSIONS: Among acutely ill medical patients with an elevated d-dimer level, there was no significant difference between extended-duration betrixaban and a standard regimen of enoxaparin in the prespecified primary efficacy outcome. However, prespecified exploratory analyses provided evidence suggesting a benefit for betrixaban in the two larger cohorts. (Funded by Portola Pharmaceuticals; APEX ClinicalTrials.gov number, NCT01583218.)